|
Home
>
Newsletters
>
International Pharmaceutical Regulatory Monitor
> Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme
International Pharmaceutical Regulatory Monitor
August 2012
| Vol.
40 No.
8
Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme
Negotiations on the future of UK pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI).
|
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.